Target intelligence / Profile preview

E3 ubiquitin-protein ligase RNF38 (RNF38)

Target
RNF38
Molecular classification
Enzyme, E3 ubiquitin ligase, RING finger protein, Nuclear protein
01

Overview

E3 ubiquitin-protein ligase RNF38 (RNF38) is a member of the RING finger protein family, characterized by a RING-H2 zinc-binding domain and a coiled-coil motif[4][7]. RNF38 functions as a nuclear E3 ubiquitin ligase; it interacts with the tumor suppressor p53, promoting its ubiquitination both in vitro and in vivo, and potentially altering its localization and function[1][2][7]. RNF38 also mediates ubiquitination of the transcription factor RUNX1, thereby stabilizing RUNX1 and enhancing its ability to repress erythroid differentiation[5]. RNF38 is implicated in the regulation of key cellular processes such as the cell cycle, apoptosis, and transcriptional modulation. Its gene is broadly expressed in human tissues, with known localization to chromosome 9p13—a region frequently deleted or altered in various cancers—indicating potential involvement in oncogenesis or tumor suppression[1][3][4]. RNF38 is not currently known to interact with any approved drugs, and no clinically validated biomarkers or therapeutic agents targeting this molecule have been reported.

Other names
RING finger protein 38RING-type E3 ubiquitin transferase RNF38
02

Mechanism of action

Ubiquitination of substrate proteins (e.g., p53, RUNX1) modulating their stability or activity

03

Biological functions

Protein ubiquitinationRegulation of p53 tumor suppressorModulation of transcription factor activity (e.g., RUNX1)Cell cycle regulationApoptosisSignal transduction
04

Disease associations

CancerOther (possible roles in cell differentiation, especially hematopoiesis)
05

Safety considerations

Potential for unintended effects on tumor suppressor p53 regulationPossible impact on hematopoiesis if targeted

Beyond the preview

Go deeper on E3 ubiquitin-protein ligase RNF38 (RNF38).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on E3 ubiquitin-protein ligase RNF38 (RNF38).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call